BAM
MGNX icon

Blueshift Asset Management’s MacroGenics MGNX Stock Holding History

Blueshift Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,636
Closed -$516K – 1087
2021
Q3 		$516K Buy
+24,636
New +$593K 0.03% 612

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blueshift Asset Management's MGNX Position: Q4 2021 in Review

Blueshift Asset Management sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 24,636 shares — an estimated $516K sold.

Blueshift Asset Management first reported a position in MGNX in Q3 2021 and held it in 1 quarter. The position peaked at $516K in Q3 2021. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Blueshift Asset Management reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 24,636 MacroGenics shares in Q4 2021, an estimated $516K.
  • Blueshift Asset Management first reported a position in MacroGenics in Q3 2021 and held it in 1 quarter.
  • Blueshift Asset Management's MacroGenics position peaked at $516K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.